Dr. Reddy’s Q2 FY24 financial results show 9% YoY revenue growth

Dr. Reddy’s Q2 FY24 financial results show 9% YoY revenue growth

Dr. Reddy’s Laboratories Ltd., an Indian pharma major, has unveiled its robust performance metrics for the Q2 FY24, ending September 30, 2023. Under the guidelines of the International Financial Reporting Standards (IFRS), the pharmaceutical giant reported a notable YoY revenue growth of 9%, emphasizing its strong market positioning. The company’s growth trajectory, especially in regions […]

Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V vaccine

Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V vaccine

Dr. Reddy’s Laboratories has secured the go-ahead from the Drugs Control General of India (DCGI) to begin phase 3 clinical trial for the Russian Covid-19 vaccine Sputnik V in India. The Indian pharma company plans to hold the phase 3 study on 1500 volunteers as part of the randomized, double-blind, parallel-group, placebo-controlled study. G V […]

Dr. Reddy’s, RDIF to bring Sputnik V coronavirus vaccine to India

Dr. Reddy’s, RDIF to bring Sputnik V coronavirus vaccine to India

Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories have agreed to cooperate on clinical trials and distribution of the Sputnik V coronavirus vaccine in India. After receiving regulatory approval in India, the Russian sovereign wealth fund will supply 100 million doses of the vaccine to Dr. Reddy’s. The Sputnik V coronavirus vaccine, which is […]